These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15857187)

  • 21. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
    Tambor ES; Rimer BK; Strigo TS
    Am J Med Genet; 1997 Jan; 68(1):43-9. PubMed ID: 8986274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRCA1/2 genetic testing in the community setting.
    Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
    J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
    Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
    Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.
    Digianni LM; Rue M; Emmons K; Garber JE
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):70-5. PubMed ID: 16434589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.
    Keogh LA; Southey MC; Maskiell J; Young MA; Gaff CL; Kirk J; Tucker KM; Rosenthal D; McCredie MR; Giles GG; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2258-63. PubMed ID: 15598789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
    Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
    Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
    Bottorff JL; Ratner PA; Balneaves LG; Richardson CG; McCullum M; Hack T; Chalmers K; Buxton J
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):89-95. PubMed ID: 11815405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early adoption of BRCA1/2 testing: who and why.
    Armstrong K; Weiner J; Weber B; Asch DA
    Genet Med; 2003; 5(2):92-8. PubMed ID: 12644778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Kim-Sing C; Ghadirian P; Sun P; Narod SA
    Clin Genet; 2014 Jan; 85(1):21-30. PubMed ID: 23859469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany.
    Hamann U; Liu X; Bungardt N; Ulmer HU; Bastert G; Sinn HP
    Eur J Hum Genet; 2003 Jun; 11(6):464-7. PubMed ID: 12774040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes of high-risk women toward preimplantation genetic diagnosis.
    Quinn G; Vadaparampil S; Wilson C; King L; Choi J; Miree C; Friedman S
    Fertil Steril; 2009 Jun; 91(6):2361-8. PubMed ID: 18440521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
    Krainer M; Silva-Arrieta S; FitzGerald MG; Shimada A; Ishioka C; Kanamaru R; MacDonald DJ; Unsal H; Finkelstein DM; Bowcock A; Isselbacher KJ; Haber DA
    N Engl J Med; 1997 May; 336(20):1416-21. PubMed ID: 9145678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
    Van Riel E; Wárlám-Rodenhuis CC; Verhoef S; Rutgers EJ; Ausems MG
    Eur J Cancer Care (Engl); 2010 May; 19(3):369-76. PubMed ID: 19659662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    Bando H
    Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians.
    Dekanek EW; Thull DL; Massart M; Grubs RE; Rajkovic A; Mai PL
    J Genet Couns; 2020 Feb; 29(1):122-130. PubMed ID: 31729099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awareness and attitudes concerning BRCA gene testing.
    Mogilner A; Otten M; Cunningham JD; Brower ST
    Ann Surg Oncol; 1998; 5(7):607-12. PubMed ID: 9831109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between temporal orientation and attitudes about BRCA1/2 testing among women of African descent with family histories of breast cancer.
    Edwards TA; Thompson HS; Kwate NO; Brown K; McGovern MM; Forman A; Kapil-Pair N; Jandorf L; Bovbjerg DH; Valdimarsdottir HB
    Patient Educ Couns; 2008 Aug; 72(2):276-82. PubMed ID: 18479882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.